Compounds of formula (I)
wherein one of R₁ or R₂ is piperazinyl or substituted piperazinyl and the other is alkyl or hydrogen possess oral hypoglycemic activity with the ability to lower blood sugar and are thus useful in the treatment of type II diabetes with associated insulin resistance.
式(I)化合物
其中 R₁或 R₂之一为哌嗪基或取代的哌嗪基,另一个为烷基或氢,具有口服降血糖活性,能够降低血糖,因此可用于治疗伴有胰岛素抵抗的 II 型糖尿病。